{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:51:48Z","timestamp":1791291108571,"version":"4.3.0"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"19","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The identification and functional characterization of tumor-specific genes is a prerequisite for the development of targeted cancer therapies. Using an integrated data mining and experimental validation approach for the discovery of new targets for antibody therapy of cancer, we identified PLAC1. PLAC1 is a placenta-specific gene with no detectable expression in any other normal human tissue. However, it is frequently aberrantly activated and highly expressed in a variety of tumor types, in particular breast cancer. RNAi-mediated silencing of PLAC1 in MCF-7 and BT-549 breast cancer cells profoundly impairs motility, migration, and invasion and induces a G1-S cell cycle block with nearly complete abrogation of proliferation. Knockdown of PLAC1 is associated with decreased expression of cyclin D1 and reduced phosphorylation of AKT kinase. Moreover, PLAC1 is localized on the surface of cancer cells and is accessible for antibodies which antagonize biological functions of this molecule. These features, in summary, make PLAC1 an attractive candidate for targeted immunotherapeutic approaches. [Cancer Res 2007;67(19):9528\u201334]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1350","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T15:03:18Z","timestamp":1191250998000},"page":"9528-9534","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["A Placenta-Specific Gene Ectopically Activated in Many Human Cancers Is Essentially Involved in Malignant Cell Processes"],"prefix":"10.1158","volume":"67","author":[{"given":"Michael","family":"Koslowski","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine III, Division of Experimental and Translational Oncology, Johannes Gutenberg University and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Sahin","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine III, Division of Experimental and Translational Oncology, Johannes Gutenberg University and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Mitnacht-Kraus","sequence":"additional","affiliation":[{"name":"2Ganymed Pharmaceuticals AG, Mainz, Germany and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Seitz","sequence":"additional","affiliation":[{"name":"3Institute of Pathology, Bamberg Hospital, Bamberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Huber","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine III, Division of Experimental and Translational Oncology, Johannes Gutenberg University and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u0308zlem","family":"Tu\u0308reci","sequence":"additional","affiliation":[{"name":"2Ganymed Pharmaceuticals AG, Mainz, Germany and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"2022061623242680900_B1","doi-asserted-by":"crossref","unstructured":"Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol\u20082005; 23: 1147\u201357.","DOI":"10.1038\/nbt1137"},{"key":"2022061623242680900_B2","doi-asserted-by":"crossref","unstructured":"Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov\u20082003; 2: 52\u201362.","DOI":"10.1038\/nrd984"},{"key":"2022061623242680900_B3","doi-asserted-by":"crossref","unstructured":"Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer\u20082001; 1: 118\u201329.","DOI":"10.1038\/35101072"},{"key":"2022061623242680900_B4","doi-asserted-by":"crossref","unstructured":"Houshmand P, Zlotnik A. Targeting tumor cells. Curr Opin Cell Biol\u20082003; 15: 640\u20134.","DOI":"10.1016\/S0955-0674(03)00106-6"},{"key":"2022061623242680900_B5","doi-asserted-by":"crossref","unstructured":"Beard J. Embryological aspects and etiology of carcinoma. Lancet\u20081902; 1: 1758\u201363.","DOI":"10.1016\/S0140-6736(01)89936-0"},{"key":"2022061623242680900_B6","doi-asserted-by":"crossref","unstructured":"Gurchot C. The trophoblast theory of cancer revisited. Oncology\u20081975; 31: 310\u20133.","DOI":"10.1159\/000225037"},{"key":"2022061623242680900_B7","doi-asserted-by":"crossref","unstructured":"Acevedo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin-\u03b2 subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer\u20081995; 76: 1467\u201375.","DOI":"10.1002\/1097-0142(19951015)76:8<1467::AID-CNCR2820760826>3.0.CO;2-A"},{"key":"2022061623242680900_B8","doi-asserted-by":"crossref","unstructured":"Dirnhofer S, Koessler P, Ensinger C, Feichtinger H, Madersbacher S, Berger P. Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade. Hum Pathol\u20081998; 29: 377\u201382.","DOI":"10.1016\/S0046-8177(98)90119-8"},{"key":"2022061623242680900_B9","doi-asserted-by":"crossref","unstructured":"Iles RK, Chard T. Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol\u20081991; 145: 453\u20138.","DOI":"10.1016\/S0022-5347(17)38367-2"},{"key":"2022061623242680900_B10","doi-asserted-by":"crossref","unstructured":"Laurence DJ, Neville AM. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer\u20081972; 26: 335\u201355.","DOI":"10.1038\/bjc.1972.45"},{"key":"2022061623242680900_B11","doi-asserted-by":"crossref","unstructured":"Koslowski M, Bell C, Seitz G, et al. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res\u20082004; 64: 5988\u201393.","DOI":"10.1158\/0008-5472.CAN-04-1187"},{"key":"2022061623242680900_B12","doi-asserted-by":"crossref","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer\u20082005; 5: 615\u201325.","DOI":"10.1038\/nrc1669"},{"key":"2022061623242680900_B13","doi-asserted-by":"crossref","unstructured":"Koslowski M, Sahin U, Huber C, Tureci O. The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes. Hum Mol Genet\u20082006; 15: 2392\u20139.","DOI":"10.1093\/hmg\/ddl163"},{"key":"2022061623242680900_B14","unstructured":"Koslowski M, Tureci O, Bell C, et al. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res\u20082002; 62: 6750\u20135."},{"key":"2022061623242680900_B15","unstructured":"Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R. Cancer gene discovery using digital differential display. Cancer Res\u20082000; 60: 4037\u201343."},{"key":"2022061623242680900_B16","doi-asserted-by":"crossref","unstructured":"Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet\u20082000; 16: 276\u20137.","DOI":"10.1016\/S0168-9525(00)02024-2"},{"key":"2022061623242680900_B17","doi-asserted-by":"crossref","unstructured":"Jones DT, Taylor WR, Thornton JM. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry\u20081994; 33: 3038\u201349.","DOI":"10.1021\/bi00176a037"},{"key":"2022061623242680900_B18","unstructured":"Hofmann K, Stoffel W. TMbase - A databse of membrane spanning protein segments. Biol Chem Hoppe-Seyler\u20081993; 374: 166."},{"key":"2022061623242680900_B19","doi-asserted-by":"crossref","unstructured":"Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol\u20081978; 120: 97\u2013120.","DOI":"10.1016\/0022-2836(78)90297-8"},{"key":"2022061623242680900_B20","doi-asserted-by":"crossref","unstructured":"Fant M, Weisoly DL, Cocchia M, et al. PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev\u20082002; 63: 430\u20136.","DOI":"10.1002\/mrd.10200"},{"key":"2022061623242680900_B21","doi-asserted-by":"crossref","unstructured":"Cocchia M, Huber R, Pantano S, et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics\u20082000; 68: 305\u201312.","DOI":"10.1006\/geno.2000.6302"},{"key":"2022061623242680900_B22","doi-asserted-by":"crossref","unstructured":"De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A\u20081996; 93: 7149\u201353.","DOI":"10.1073\/pnas.93.14.7149"},{"key":"2022061623242680900_B23","doi-asserted-by":"crossref","unstructured":"De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol\u20081999; 19: 7327\u201335.","DOI":"10.1128\/MCB.19.11.7327"},{"key":"2022061623242680900_B24","doi-asserted-by":"crossref","unstructured":"Honda T, Tamura G, Waki T, et al. Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer\u20082004; 90: 838\u201343.","DOI":"10.1038\/sj.bjc.6601600"},{"key":"2022061623242680900_B25","doi-asserted-by":"crossref","unstructured":"Bork P, Sander C. A large domain common to sperm receptors (Zp2 and Zp3) and TGF-\u03b2 type III receptor. FEBS Lett\u20081992; 300: 237\u201340.","DOI":"10.1016\/0014-5793(92)80853-9"},{"key":"2022061623242680900_B26","doi-asserted-by":"crossref","unstructured":"Jovine L, Janssen WG, Litscher ES, Wassarman PM. The PLAC1-homology region of the ZP domain is sufficient for protein polymerisation. BMC Biochem\u20082006; 7: 11.","DOI":"10.1186\/1471-2091-7-11"},{"key":"2022061623242680900_B27","doi-asserted-by":"crossref","unstructured":"Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol\u20081997; 13: 261\u201391.","DOI":"10.1146\/annurev.cellbio.13.1.261"},{"key":"2022061623242680900_B28","unstructured":"Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res\u20082000; 60: 3689\u201395."},{"key":"2022061623242680900_B29","doi-asserted-by":"crossref","unstructured":"Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem\u20082006; 97: 261\u201374.","DOI":"10.1002\/jcb.20690"},{"key":"2022061623242680900_B30","doi-asserted-by":"crossref","unstructured":"Sutherland RL, Musgrove EA. Cyclins and breast cancer. J Mammary Gland Biol Neoplasia\u20082004; 9: 95\u2013104.","DOI":"10.1023\/B:JOMG.0000023591.45568.77"},{"key":"2022061623242680900_B31","doi-asserted-by":"crossref","unstructured":"Sherr CJ. Mammalian G1 cyclins. Cell\u20081993; 73: 1059\u201365.","DOI":"10.1016\/0092-8674(93)90636-5"},{"key":"2022061623242680900_B32","doi-asserted-by":"crossref","unstructured":"D'Amico M, Hulit J, Amanatullah DF, et al. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3\u03b2 and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem\u20082000; 275: 32649\u201357.","DOI":"10.1074\/jbc.M000643200"},{"key":"2022061623242680900_B33","doi-asserted-by":"crossref","unstructured":"Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase\/Akt-dependent pathway. J Biol Chem\u20081998; 273: 29864\u201372.","DOI":"10.1074\/jbc.273.45.29864"},{"key":"2022061623242680900_B34","doi-asserted-by":"crossref","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3\u03b2 regulates cyclin D1 proteolysis and subcellular localization. Genes Dev\u20081998; 12: 3499\u2013511.","DOI":"10.1101\/gad.12.22.3499"},{"key":"2022061623242680900_B35","doi-asserted-by":"crossref","unstructured":"Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol\u20082003; 23: 6139\u201349.","DOI":"10.1128\/MCB.23.17.6139-6149.2003"},{"key":"2022061623242680900_B36","doi-asserted-by":"crossref","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science\u20082002; 296: 1655\u20137.","DOI":"10.1126\/science.296.5573.1655"},{"key":"2022061623242680900_B37","doi-asserted-by":"crossref","unstructured":"Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell\u20082003; 4: 257\u201362.","DOI":"10.1016\/S1535-6108(03)00248-4"},{"key":"2022061623242680900_B38","doi-asserted-by":"crossref","unstructured":"Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science\u20081989; 244: 707\u201312.","DOI":"10.1126\/science.2470152"},{"key":"2022061623242680900_B39","doi-asserted-by":"crossref","unstructured":"Massabbal E, Parveen S, Weisoly DL, Nelson DM, Smith SD, Fant M. PLAC1 expression increases during trophoblast differentiation: evidence for regulatory interactions with the fibroblast growth factor-7 (FGF-7) axis. Mol Reprod Dev\u20082005; 71: 299\u2013304.","DOI":"10.1002\/mrd.20272"},{"key":"2022061623242680900_B40","doi-asserted-by":"crossref","unstructured":"Attisano L, Wrana JL, Lopez-Casillas F, Massague J. TGF-\u03b2 receptors and actions. Biochim Biophys Acta\u20081994; 1222: 71\u201380.","DOI":"10.1016\/0167-4889(94)90026-4"},{"key":"2022061623242680900_B41","doi-asserted-by":"crossref","unstructured":"Derynck R, Feng XH. TGF-\u03b2 receptor signaling. Biochim Biophys Acta\u20081997; 1333: 105\u201350.","DOI":"10.1016\/S0304-419X(97)00017-6"},{"key":"2022061623242680900_B42","doi-asserted-by":"crossref","unstructured":"Sexton PM, Albiston A, Morfis M, Tilakaratne N. Receptor activity modifying proteins. Cell Signal\u20082001; 13: 73\u201383.","DOI":"10.1016\/S0898-6568(00)00143-1"},{"key":"2022061623242680900_B43","doi-asserted-by":"crossref","unstructured":"Udawela M, Hay DL, Sexton PM. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol\u20082004; 15: 299\u2013308.","DOI":"10.1016\/j.semcdb.2003.12.019"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/19\/9528\/2573373\/9528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/19\/9528\/2573373\/9528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:35:51Z","timestamp":1655422551000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/19\/9528\/533496\/A-Placenta-Specific-Gene-Ectopically-Activated-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":43,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2007,10,1]]},"published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1350","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22368411.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368414.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368417.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368420","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368411","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368420.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368414","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368417","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495948.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495948","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}